Skip to content

Direct-acting antivirals bring fewer HCV-related liver transplants, better survival after transplantation, in Europe

Chiara Mazzarelli, one of the study researchers, at The International Liver Congress, 2018. Photo by Liz Highleyman.

Researchers puzzle over whether HIV accelerates cancer progression

Eight weeks of treatment with Epclusa cured almost all people with HCV receiving opioid substitution therapy

Alison Boyle presenting at The International Liver Congress, 2018. Image credit: @katjc1

New affordable hepatitis C combination shows 97% cure rate

Interim results from the STORM-C-1 study. Image credit: @DNDi

First-line ART failure common among hospitalised HIV-positive people in sub-Saharan Africa

More time with depression increases the risk of death for women with HIV

TAF only superior to TDF when used with a boosting agent

Non-consensual sex is a recurrent problem in the chemsex environment

REALITY study shows which HIV-positive people with very low CD4 cell counts are at highest risk of dying soon after starting treatment